Elon Musk to begin testing on human brains

Source: James Duncan Davidson (CC BY-NC 3.0)

Elon Musk's company Neuralink received approval from the U.S. Food and Drug Administration (FDA) on May 25 to begin the first human trials.

"We are excited to share the news that we have received FDA approval to start the first clinical trials on humans. This is the result of the incredible work of the Neuralink team in close collaboration with the FDA. This is the first step that will eventually allow technology to help many people," the company stated.

It was emphasized that recruitment for the trials has not yet begun, and the company will provide more information about the planned studies in the near future.

Neuralink attempted to obtain approval for human trials last year, but their request was rejected by the FDA. The FDA identified a number of issues related to the implants that the company intends to implant in the brain, such as the lithium battery in the device and the problem of safely removing it without damaging brain tissue. The agency refused to grant approval until the company resolves these issues.


elon musk

More News


12 hours ago

Villeroy & Boch Celebrates 275th Anniversary

1 day ago

Responsible and conscious design. We talk to London-based designer David Girelli

2 days ago

A feminine flourish in the bathroom: The home of architect Anna Koszela

8 days ago

Polish design at its best available for auction at DESA Unicum

Book of Lists

Book of Lists
2 years ago

The largest Polish companies under the Book of Lists microscope! Book of Lists 2020/2021 certificates have been awarded.

Book of Lists
3 years ago

25th jubilee edition of Book of Lists – project start